News
AML maintenance: It’s now a thing
- Author:
- Neil Osterweil
New post-remission therapies for acute myeloid leukemia can for the first time improve relapse-free and overall...
News
HMAs plus novel agents may improve outcomes in higher-risk MDS
- Author:
- Neil Osterweil
Hypomethylating agents are still the standard of care, but pairing them with other therapies can improve...
News
TKI choice key for fit/unfit patients with Ph+ALL
- Author:
- Neil Osterweil
Ponatinib (Iclusig) is associated with high response rates in combination therapy, but toxicities may be too great for less fit patients.
News
For lower-risk MDS, treat ‘what bugs patients most’
- Author:
- Neil Osterweil
There are no therapies known to extend survival of low-risk MDS, but many patients can have a good quality of...
News
Fatal pediatric melanomas diverse in presentation
- Author:
- Neil Osterweil
One-fourth of fatal pediatric melanomas arose in association with congenital melanocytic nevi.
News
Coronavirus-associated aspergillosis increased 30-day mortality risk
- Author:
- Neil Osterweil
Nearly one-third of patients on mechanical ventilation for COVID-19 had probable coronavirus-associated pulmonary aspergillosis.
News
Swallowable ‘sponge on string’ to diagnose esophageal cancer
- Author:
- Neil Osterweil
A swallowable device consisting of a sponge in a capsule successfully identified Barrett’s esophagus and cancer...
News
Swallowable ‘sponge on string’ to diagnose esophageal cancer
- Author:
- Neil Osterweil
A swallowable device consisting of a sponge in a capsule successfully identified Barrett’s esophagus and cancer...
News
Ultrasound, cardiac CT valuable in COVID-19 assessment
- Author:
- Neil Osterweil
An expert panel of the American College of Cardiology offers evidence-based guidance for evaluating cardiac complications of COVID-19 infections...
News
Ready for PRIME time? Newly ID’d cells predict RA flares
- Author:
- Neil Osterweil
Preinflammatory mesenchymal cells resembling synovial fibroblasts may be markers for flare or potential therapeutic targets.
News
The wheels on the bus take lung cancer screening to rural areas
- Author:
- Neil Osterweil
A commercial bus, modified to carry a mobile CT screening unit, has been reaching high-risk individuals in rural areas who may have otherwise been...
News
USPSTF: Earlier lung cancer screening can double eligibility
- Author:
- Neil Osterweil
New proposals to start screening at age 50 rather than 55, and after 20 rather than 30 pack-years of smoking, could benefit Black and female...
News
Brensocatib reduced bronchiectasis exacerbations
- Author:
- Neil Osterweil
The investigational DPP1 inhibitor is a nonantibiotic anti-inflammatory agent designed to reduce neutrophil...
News
Inhaled treprostinil improves walk distance in patients with ILD-associated pulmonary hypertension
- Author:
- Neil Osterweil
Clinical worsening was reduced for patients with interstitial lung disease–associated pulmonary hypertension, compared with placebo.
News
Sotatercept reversed vascular remodeling in patients with PAH
- Author:
- Neil Osterweil
The investigational fusion protein sotatercept is thought to reduce pulmonary vascular resistance by reversing remodeling.